Suchergebnisse - "Cyclophosphamide"

Splenectomy following rituximab and cyclophosphamide for severe autoimmune hemolytic anemia in pregnancy.

Autoren: Wang T Yang J Peng B et al.

Quelle: Hematology (Amsterdam, Netherlands) [Hematology] 2025 Dec; Vol. 30 (1), pp. 2516885. Date of Electronic Publication: 2025 Jun 16.

Publikationsart: Journal Article; Case Reports

Info zur Zeitschrift: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1607-8454 (Electronic) Linking ISSN: 10245332 NLM ISO Abbreviation: Hematology Subsets: MEDLINE

MeSH-Schlagworte: Anemia, Hemolytic, Autoimmune*/drug therapy , Anemia, Hemolytic, Autoimmune*/surgery , Anemia, Hemolytic, Autoimmune*/therapy , Rituximab*/therapeutic use , Rituximab*/administration & dosage , Splenectomy* , Cyclophosphamide*/therapeutic use , Cyclophosphamide*/administration & dosage , Pregnancy Complications, Hematologic*/drug therapy , Pregnancy Complications, Hematologic*/surgery , Pregnancy Complications, Hematologic*/therapy, Humans ; Female ; Pregnancy ; Adult ; Infant, Newborn

Outcomes of BTD vs. BCD as initial treatment of renal amyloid light-chain amyloidosis: a retrospective cohort study in China.

Autoren: Li S He W Yau HH et al.

Quelle: Renal failure [Ren Fail] 2025 Dec; Vol. 47 (1), pp. 2453006. Date of Electronic Publication: 2025 Feb 24.

Publikationsart: Journal Article; Comparative Study

Info zur Zeitschrift: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8701128 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-6049 (Electronic) Linking ISSN: 0886022X NLM ISO Abbreviation: Ren Fail Subsets: MEDLINE

MeSH-Schlagworte: Bortezomib*/administration & dosage , Bortezomib*/therapeutic use , Bortezomib*/adverse effects , Immunoglobulin Light-chain Amyloidosis*/drug therapy , Immunoglobulin Light-chain Amyloidosis*/complications , Dexamethasone*/therapeutic use , Dexamethasone*/administration & dosage , Dexamethasone*/adverse effects , Cyclophosphamide*/therapeutic use , Cyclophosphamide*/administration & dosage , Cyclophosphamide*/adverse effects , Thalidomide*/therapeutic use , Thalidomide*/administration & dosage , Thalidomide*/adverse effects , Kidney Diseases*/drug therapy, Humans ; Male ; Female ; Retrospective Studies ; Middle Aged ; China ; Aged ; Treatment Outcome ; Propensity Score ; Kidney Failure, Chronic/etiology ; Adult ; Drug Therapy, Combination

Cancer immunotherapeutic targeting tropomyosin receptor kinase C (TrkC) through its conjugate and cyclophosphamide.

Autoren: Bakar SN Kiew LV Chung LY et al.

Quelle: Immunopharmacology and immunotoxicology [Immunopharmacol Immunotoxicol] 2025 Dec; Vol. 47 (6), pp. 772-781. Date of Electronic Publication: 2025 Oct 16.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Informa Healthcare Country of Publication: England NLM ID: 8800150 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-2513 (Electronic) Linking ISSN: 08923973 NLM ISO Abbreviation: Immunopharmacol Immunotoxicol Subsets: MEDLINE

MeSH-Schlagworte: Cyclophosphamide*/pharmacology , Cyclophosphamide*/administration & dosage , Receptor, trkC*/immunology , Receptor, trkC*/antagonists & inhibitors , Immunotherapy*/methods , Mammary Neoplasms, Experimental*/immunology , Mammary Neoplasms, Experimental*/drug therapy , Mammary Neoplasms, Experimental*/pathology, Animals ; Female ; Mice ; Mice, Inbred BALB C ; Cell Line, Tumor

Spinosin Alleviates Cyclophosphamide-Induced Oxidative Stress, Inflammation, and Apoptosis in Liver and Kidney Injury in Mice.

Autoren: Demirel HH Zemheri-Navruz F Tureyen A et al.

Quelle: Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2025 Nov; Vol. 39 (11), pp. e70603.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Wiley Country of Publication: United States NLM ID: 9717231 Publication Model: Print Cited Medium: Internet ISSN: 1099-0461 (Electronic) Linking ISSN: 10956670 NLM ISO Abbreviation: J Biochem Mol Toxicol Subsets: MEDLINE

MeSH-Schlagworte: Cyclophosphamide*/adverse effects , Cyclophosphamide*/toxicity , Oxidative Stress*/drug effects , Apoptosis*/drug effects , Inflammation*/chemically induced , Inflammation*/drug therapy , Inflammation*/metabolism , Inflammation*/pathology , Chemical and Drug Induced Liver Injury*/pathology , Chemical and Drug Induced Liver Injury*/metabolism , Chemical and Drug Induced Liver Injury*/drug therapy , Chemical and Drug Induced Liver Injury*/prevention & control , Kidney*/metabolism , Kidney*/pathology , Kidney*/drug effects , Liver*/metabolism , Liver*/pathology , Liver*/drug effects , Acute Kidney Injury*/chemically induced , Acute Kidney Injury*/metabolism , Acute Kidney Injury*/pathology , Acute Kidney Injury*/drug therapy, Animals ; Mice ; Male

Graft-versus-host disease is not associated with reduced incidence of relapse following haploidentical stem cell transplantation with post-transplant cyclophosphamide for acute lymphoblastic leukaemia: A study on behalf of the Acute Leukaemia Working Party of European Society for Blood and Marrow Transplantation.

Autoren: Shimoni A Peczynski C Labopin M et al.

Quelle: British journal of haematology [Br J Haematol] 2025 Nov; Vol. 207 (5), pp. 2041-2048. Date of Electronic Publication: 2025 Aug 14.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE

MeSH-Schlagworte: Graft vs Host Disease*/etiology , Graft vs Host Disease*/epidemiology , Graft vs Host Disease*/mortality , Cyclophosphamide*/therapeutic use , Cyclophosphamide*/administration & dosage , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/therapy , Precursor Cell Lymphoblastic Leukemia-Lymphoma*/mortality , Hematopoietic Stem Cell Transplantation*/methods , Hematopoietic Stem Cell Transplantation*/adverse effects, Humans ; Adult ; Female ; Male ; Middle Aged ; Incidence ; Adolescent ; Recurrence ; Transplantation, Haploidentical ; Young Adult ; Aged

Melatonin alleviates cyclophosphamide-induced ovarian toxicity in mice.

Autoren: Oubiña G May M Bianchi MS et al.

Quelle: Journal of assisted reproduction and genetics [J Assist Reprod Genet] 2025 Nov; Vol. 42 (11), pp. 3695-3712. Date of Electronic Publication: 2025 Sep 16.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Springer Country of Publication: Netherlands NLM ID: 9206495 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7330 (Electronic) Linking ISSN: 10580468 NLM ISO Abbreviation: J Assist Reprod Genet Subsets: MEDLINE

MeSH-Schlagworte: Cyclophosphamide*/adverse effects , Cyclophosphamide*/toxicity , Melatonin*/pharmacology , Primary Ovarian Insufficiency*/chemically induced , Primary Ovarian Insufficiency*/drug therapy , Primary Ovarian Insufficiency*/pathology , Ovary*/drug effects , Ovary*/pathology, Animals ; Female ; Mice ; Ovarian Follicle/drug effects ; Ovarian Follicle/pathology ; Ovarian Follicle/growth & development ; Apoptosis/drug effects ; Antioxidants/pharmacology ; Fertility Preservation/methods ; Disease Models, Animal ; Humans ; Antineoplastic Agents, Alkylating

Successful Treatment of Refractory TAFRO Syndrome with Cyclophosphamide: A Report of Two Cases.

Autoren: Nakamura K Miki K Ota S et al.

Quelle: Internal medicine (Tokyo, Japan) [Intern Med] 2025 Nov 01; Vol. 64 (21), pp. 3130-3134. Date of Electronic Publication: 2025 Apr 19.

Publikationsart: Journal Article; Case Reports

Info zur Zeitschrift: Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE

MeSH-Schlagworte: Castleman Disease*/drug therapy , Castleman Disease*/diagnosis , Cyclophosphamide*/therapeutic use , Cyclophosphamide*/administration & dosage , Fever*/drug therapy , Fever*/diagnosis , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/administration & dosage , Primary Myelofibrosis*/drug therapy , Primary Myelofibrosis*/diagnosis , Thrombocytopenia*/drug therapy , Thrombocytopenia*/diagnosis, Humans ; Edema/drug therapy ; Edema/diagnosis ; Treatment Outcome

SCR Disease Name: Multi-centric Castleman's Disease

Protective Efficacy of Protocatechuic Acid Against Cyclophosphamide-Induced Nephrotoxicity in Small White Mice.

Autoren: Kabir F Marashi NS Goudarzi M et al.

Quelle: Journal of biochemical and molecular toxicology [J Biochem Mol Toxicol] 2025 Nov; Vol. 39 (11), pp. e70572.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Wiley Country of Publication: United States NLM ID: 9717231 Publication Model: Print Cited Medium: Internet ISSN: 1099-0461 (Electronic) Linking ISSN: 10956670 NLM ISO Abbreviation: J Biochem Mol Toxicol Subsets: MEDLINE

MeSH-Schlagworte: Cyclophosphamide*/adverse effects , Cyclophosphamide*/toxicity , Hydroxybenzoates*/pharmacology , Kidney*/metabolism , Kidney*/pathology , Kidney*/drug effects , Kidney Diseases*/chemically induced , Kidney Diseases*/prevention & control , Kidney Diseases*/pathology, Animals ; Male ; Mice ; Antioxidants/pharmacology ; Oxidative Stress/drug effects

Decoding premature ovarian insufficiency: A full spectrum review from epidemiology to management with emphasis on cyclophosphamide-evoked ovarian injury.

Autoren: Sharata EE Attya ME Khalaf MM et al.

Quelle: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association [Food Chem Toxicol] 2025 Nov; Vol. 205, pp. 115719. Date of Electronic Publication: 2025 Aug 29.

Publikationsart: Journal Article; Review

Info zur Zeitschrift: Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 8207483 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-6351 (Electronic) Linking ISSN: 02786915 NLM ISO Abbreviation: Food Chem Toxicol Subsets: MEDLINE

MeSH-Schlagworte: Primary Ovarian Insufficiency*/epidemiology , Primary Ovarian Insufficiency*/chemically induced , Primary Ovarian Insufficiency*/therapy , Cyclophosphamide*/adverse effects , Cyclophosphamide*/toxicity , Ovary*/drug effects , Antineoplastic Agents, Alkylating*/adverse effects, Humans ; Female ; Animals ; Oxidative Stress/drug effects

Antithymocyte globulin and posttransplant cyclophosphamide in graft vs. host disease prophylaxis: comparison or combination.

Autoren: Barriga F; Section of Pediatric Hematology, Oncology and Transplantation. Pontifical Catholic University of Chile, Chile.

Quelle: Current opinion in hematology [Curr Opin Hematol] 2025 Nov 01; Vol. 32 (6), pp. 301-307. Date of Electronic Publication: 2025 Jul 07.

Publikationsart: Journal Article; Review; Comparative Study

Info zur Zeitschrift: Publisher: Lippincott Williams And Wilkins Country of Publication: United States NLM ID: 9430802 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-7048 (Electronic) Linking ISSN: 10656251 NLM ISO Abbreviation: Curr Opin Hematol Subsets: MEDLINE

MeSH-Schlagworte: Antilymphocyte Serum*/therapeutic use , Antilymphocyte Serum*/administration & dosage , Cyclophosphamide*/therapeutic use , Cyclophosphamide*/administration & dosage , Graft vs Host Disease*/prevention & control , Graft vs Host Disease*/etiology , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods , Immunosuppressive Agents*/therapeutic use, Humans

Long-term efficacy of rituximab versus intravenous cyclophosphamide for severe ANCA-associated vasculitis in multicenter REVEAL cohort study.

Autoren: Matsuda S Kotani T Nishioka D et al.

Quelle: Journal of internal medicine [J Intern Med] 2025 Nov; Vol. 298 (5), pp. 504-515. Date of Electronic Publication: 2025 Sep 22.

Publikationsart: Journal Article; Multicenter Study; Comparative Study

Info zur Zeitschrift: Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 8904841 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2796 (Electronic) Linking ISSN: 09546820 NLM ISO Abbreviation: J Intern Med Subsets: MEDLINE

MeSH-Schlagworte: Rituximab*/therapeutic use , Rituximab*/administration & dosage , Rituximab*/adverse effects , Cyclophosphamide*/administration & dosage , Cyclophosphamide*/therapeutic use , Cyclophosphamide*/adverse effects , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/drug therapy , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/mortality , Immunosuppressive Agents*/administration & dosage , Immunosuppressive Agents*/therapeutic use, Humans ; Male ; Female ; Middle Aged ; Aged ; Remission Induction ; Treatment Outcome ; Microscopic Polyangiitis/drug therapy ; Granulomatosis with Polyangiitis/drug therapy ; Administration, Intravenous ; Glucocorticoids/therapeutic use ; Recurrence ; Adult

Comparison of Haploidentical-Hematopoietic Stem Cell Transplantation Using Modified Post-Transplantation Cyclophosphamide and Eltrombopag Combined With Immunosuppression for the Treatment of Severe Aplastic Anemia.

Autoren: Fu A Li M Peng Y et al.

Quelle: Transplantation and cellular therapy [Transplant Cell Ther] 2025 Nov; Vol. 31 (11), pp. 900.e1-900.e13. Date of Electronic Publication: 2025 Aug 09.

Publikationsart: Journal Article; Comparative Study; Multicenter Study

Info zur Zeitschrift: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

MeSH-Schlagworte: Anemia, Aplastic*/therapy , Anemia, Aplastic*/mortality , Cyclophosphamide*/therapeutic use , Cyclophosphamide*/pharmacology , Hematopoietic Stem Cell Transplantation*/methods , Hydrazines*/therapeutic use , Benzoates*/therapeutic use , Pyrazoles*/therapeutic use , Transplantation, Haploidentical*/methods , Immunosuppressive Agents*/therapeutic use , Immunosuppression Therapy*/methods, Humans ; Female ; Male ; Adult ; Adolescent ; Child ; Young Adult ; Middle Aged ; Child, Preschool ; Treatment Outcome

Rituximab, tacrolimus, cyclophosphamide and cyclosporin in primary membranous nephropathy with nephrotic syndrome: comparison of safety profiles, effect on remission rate, 24-h urinary total protein, serum albumin, and serum creatinine levels using network meta-analysis.

Autoren: Cai N Zhu SY Huang JJ et al.

Quelle: International urology and nephrology [Int Urol Nephrol] 2025 Nov; Vol. 57 (11), pp. 3733-3750. Date of Electronic Publication: 2025 May 08.

Publikationsart: Comparative Study; Journal Article; Network Meta-Analysis

Info zur Zeitschrift: Publisher: Springer Country of Publication: Netherlands NLM ID: 0262521 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-2584 (Electronic) Linking ISSN: 03011623 NLM ISO Abbreviation: Int Urol Nephrol Subsets: MEDLINE

MeSH-Schlagworte: Cyclophosphamide*/therapeutic use , Cyclophosphamide*/adverse effects , Cyclosporine*/therapeutic use , Cyclosporine*/adverse effects , Glomerulonephritis, Membranous*/drug therapy , Glomerulonephritis, Membranous*/complications , Glomerulonephritis, Membranous*/blood , Glomerulonephritis, Membranous*/urine , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/adverse effects , Nephrotic Syndrome*/drug therapy , Nephrotic Syndrome*/complications , Nephrotic Syndrome*/etiology , Nephrotic Syndrome*/blood , Rituximab*/therapeutic use , Rituximab*/adverse effects , Tacrolimus*/therapeutic use , Tacrolimus*/adverse effects, Humans ; Creatinine/blood ; Drug Therapy, Combination ; Network Meta-Analysis as Topic ; Proteinuria/urine ; Randomized Controlled Trials as Topic ; Remission Induction ; Serum Albumin/analysis ; Serum Albumin/metabolism

Establishment of an optimized chemotherapy-induced mouse model for premature ovarian failure: protocol and findings.

Autoren: Yavari N Zaeemzadeh N Gharesi-Fard B et al.

Quelle: Aging [Aging (Albany NY)] 2025 Oct 28; Vol. 17 (10), pp. 2637-2649. Date of Electronic Publication: 2025 Oct 28.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Impact Journals, LLC Country of Publication: United States NLM ID: 101508617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1945-4589 (Electronic) Linking ISSN: 19454589 NLM ISO Abbreviation: Aging (Albany NY) Subsets: MEDLINE

MeSH-Schlagworte: Primary Ovarian Insufficiency*/chemically induced , Primary Ovarian Insufficiency*/blood , Cyclophosphamide*/toxicity , Cyclophosphamide*/administration & dosage , Cyclophosphamide*/adverse effects , Disease Models, Animal* , Busulfan*/toxicity , Busulfan*/administration & dosage, Animals ; Female ; Mice ; Ovarian Follicle/drug effects ; Ovary/drug effects ; Anti-Mullerian Hormone/blood ; Follicle Stimulating Hormone/blood

Low- and high-dose post-transplant cyclophosphamide attenuates graft-versus-host disease with distinct effects on PD-1+ T cell subsets.

Autoren: Sligar C Jacobs MJ Elhage A et al.

Quelle: Clinical science (London, England : 1979) [Clin Sci (Lond)] 2025 Oct 28; Vol. 139 (21). Date of Electronic Publication: 2025 Oct 28.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Portland Press on behalf of the Medical Research Society and the Biochemical Society Country of Publication: England NLM ID: 7905731 Publication Model: Electronic Cited Medium: Internet ISSN: 1470-8736 (Electronic) Linking ISSN: 01435221 NLM ISO Abbreviation: Clin Sci (Lond) Subsets: MEDLINE

MeSH-Schlagworte: Cyclophosphamide*/administration & dosage , Cyclophosphamide*/pharmacology , Graft vs Host Disease*/prevention & control , Graft vs Host Disease*/immunology , Graft vs Host Disease*/drug therapy , Hematopoietic Stem Cell Transplantation*/adverse effects , Programmed Cell Death 1 Receptor*/metabolism , Programmed Cell Death 1 Receptor*/immunology , T-Lymphocyte Subsets*/drug effects , T-Lymphocyte Subsets*/immunology , T-Lymphocyte Subsets*/metabolism , Immunosuppressive Agents*/administration & dosage , Immunosuppressive Agents*/pharmacology, Animals ; Humans ; Mice, Inbred NOD ; Mice ; Mice, SCID ; Female ; Male ; Dose-Response Relationship, Drug ; Disease Models, Animal

Efficacy and safety of rituximab versus intravenous cyclophosphamide for systemic sclerosis-associated interstitial lung disease: a retrospective cohort study.

Autoren: Hiura R Ayano M Uchino A et al.

Quelle: Arthritis research & therapy [Arthritis Res Ther] 2025 Oct 17; Vol. 27 (1), pp. 193. Date of Electronic Publication: 2025 Oct 17.

Publikationsart: Journal Article; Comparative Study

Info zur Zeitschrift: Publisher: BioMed Central Country of Publication: England NLM ID: 101154438 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-6362 (Electronic) Linking ISSN: 14786354 NLM ISO Abbreviation: Arthritis Res Ther Subsets: MEDLINE

MeSH-Schlagworte: Cyclophosphamide*/administration & dosage , Cyclophosphamide*/adverse effects , Cyclophosphamide*/therapeutic use , Lung Diseases, Interstitial*/drug therapy , Lung Diseases, Interstitial*/etiology , Rituximab*/adverse effects , Rituximab*/administration & dosage , Rituximab*/therapeutic use , Scleroderma, Systemic*/complications , Scleroderma, Systemic*/drug therapy , Immunosuppressive Agents*/administration & dosage , Immunosuppressive Agents*/adverse effects, Humans ; Retrospective Studies ; Female ; Male ; Middle Aged ; Treatment Outcome ; Adult ; Aged ; Administration, Intravenous ; Vital Capacity/drug effects ; Cohort Studies

Salvage HLA-haploidentical Peripheral Blood Stem Cell Transplantation Using Post-transplant Cyclophosphamide for Recurrent Hemophagocytic Lymphohistiocytosis-associated Graft Failure after Cord Blood Transplantations.

Autoren: Sato K Komaba W Oka S et al.

Quelle: Internal medicine (Tokyo, Japan) [Intern Med] 2025 Oct 15; Vol. 64 (20), pp. 3012-3019. Date of Electronic Publication: 2025 Apr 12.

Publikationsart: Journal Article; Case Reports

Info zur Zeitschrift: Publisher: Japanese Society of Internal Medicine Country of Publication: Japan NLM ID: 9204241 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7235 (Electronic) Linking ISSN: 09182918 NLM ISO Abbreviation: Intern Med Subsets: MEDLINE

MeSH-Schlagworte: Cord Blood Stem Cell Transplantation*/adverse effects , Cyclophosphamide*/therapeutic use , Cyclophosphamide*/administration & dosage , Graft Rejection*/therapy , Graft Rejection*/etiology , Lymphohistiocytosis, Hemophagocytic*/therapy , Lymphohistiocytosis, Hemophagocytic*/etiology , Peripheral Blood Stem Cell Transplantation*/methods , Salvage Therapy*/methods, Female ; Humans ; Male ; Graft vs Host Disease ; HLA Antigens/immunology ; Immunosuppressive Agents/therapeutic use ; Recurrence ; Transplantation, Haploidentical/methods

Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamide.

Autoren: Geetha D Neumann T Karras A et al.

Körperschaften: Geetha D Neumann T Karras A et al.

Quelle: RMD open [RMD Open] 2025 Oct 05; Vol. 11 (4). Date of Electronic Publication: 2025 Oct 05.

Publikationsart: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial

Info zur Zeitschrift: Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN: 2056-5933 (Electronic) Linking ISSN: 20565933 NLM ISO Abbreviation: RMD Open Subsets: MEDLINE

MeSH-Schlagworte: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/drug therapy , Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis*/diagnosis , Cyclophosphamide*/therapeutic use , Cyclophosphamide*/administration & dosage , Cyclophosphamide*/adverse effects , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/adverse effects , Immunosuppressive Agents*/administration & dosage, Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Drug Therapy, Combination ; Glomerular Filtration Rate ; Glucocorticoids/adverse effects ; Prednisone/therapeutic use ; Prednisone/administration & dosage ; Prednisone/adverse effects ; Remission Induction ; Treatment Outcome

Successful management of paraquat poisoning: a case report.

Autoren: Havaldar AA; Department of Critical Care Medicine, St. John's Medical College, Bangalore, 560034, India. amarjahavaldar@rediffmail.com.

Quelle: Journal of medical case reports [J Med Case Rep] 2025 Oct 03; Vol. 19 (1), pp. 479. Date of Electronic Publication: 2025 Oct 03.

Publikationsart: Journal Article; Case Reports

Info zur Zeitschrift: Publisher: BioMed Central Country of Publication: England NLM ID: 101293382 Publication Model: Electronic Cited Medium: Internet ISSN: 1752-1947 (Electronic) Linking ISSN: 17521947 NLM ISO Abbreviation: J Med Case Rep Subsets: MEDLINE

MeSH-Schlagworte: Paraquat*/poisoning , Herbicides*/poisoning , Immunosuppressive Agents*/therapeutic use , Immunosuppressive Agents*/administration & dosage , Cyclophosphamide*/therapeutic use , Cyclophosphamide*/administration & dosage, Humans ; Adult ; Male ; Female ; Acetylcysteine/therapeutic use ; Treatment Outcome ; Renal Replacement Therapy/methods ; India

Standard Versus Reduced-Doses of Post-Transplant Cyclophosphamide in HLA Matched (10/10) Peripheral Blood Stem Cell Transplantation.

Autoren: Redondo S García-Cadenas I Esquirol A et al.

Quelle: European journal of haematology [Eur J Haematol] 2025 Oct; Vol. 115 (4), pp. 413-422. Date of Electronic Publication: 2025 Jul 23.

Publikationsart: Journal Article

Info zur Zeitschrift: Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609 (Electronic) Linking ISSN: 09024441 NLM ISO Abbreviation: Eur J Haematol Subsets: MEDLINE

MeSH-Schlagworte: Cyclophosphamide*/administration & dosage , Cyclophosphamide*/adverse effects , Peripheral Blood Stem Cell Transplantation*/adverse effects , Peripheral Blood Stem Cell Transplantation*/methods , Immunosuppressive Agents*/administration & dosage , Immunosuppressive Agents*/adverse effects , HLA Antigens*/immunology, Humans ; Male ; Female ; Adult ; Middle Aged ; Graft vs Host Disease/prevention & control ; Graft vs Host Disease/etiology ; Retrospective Studies ; Treatment Outcome ; Aged ; Young Adult ; Histocompatibility Testing ; Adolescent ; Transplantation, Homologous